Synchrony Medical Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-09-12.
Synchrony Medical Inc. filed an amended Form D notice of an exempt securities offering with the SEC on September 12, 2025. The filing reports $4.30M sold. Its industry group is Biotechnology. It names Anat Shani (Executive Officer, Director), Eileen Ke (Director), Shai Policker (Director) (SEC Form D/A, September 12, 2025).
Is this your company?
Sell to companies like Synchrony Medical Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Synchrony Medical Inc.
Free to see. No signup.
More on the people and the money behind Synchrony Medical Inc., from the filings we hold.
Biotechnology raises by companies based in New Jersey, filed within 90 days of this one, largest first.
Get an email when Synchrony Medical Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Synchrony Medical Inc. raises, hires or launches. No email unless you switch it on.
Watch Synchrony Medical Inc. →Get the full cited report on Synchrony Medical Inc.
What the filing shows about Synchrony Medical Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Synchrony Medical Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Synchrony Medical Inc.'s address as 222 Jersey City Blvd., Jersey City, NJ 07305.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Synchrony Medical Inc. →
Amended on 2026-03-10: the offering size changed from $2,500,000 to $4,300,000; the amount sold changed from $1,000,000 to $4,300,000; the number of investors changed from 7 to 12. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Synchrony Medical Inc. is a registered filer with the SEC (CIK 2085429) and has filed since 2025-09-12. 2 filings are on record, the latest on 2026-03-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Synchrony Medical Inc.'s Form D of 2025-09-12 names Anat Shani, Eileen Ke, Shai Policker and 2 more as its officers, directors or promoters.
Its new offerings report $1M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Anat Shani is named as Executive Officer and Director on the Form D that Synchrony Medical Inc. filed with the SEC on 12 September 2025, one of 5 people that filing names.
Eileen Ke is named as Director on the Form D that Synchrony Medical Inc. filed with the SEC on 12 September 2025, one of 5 people that filing names.
Shai Policker is named as Director on the Form D that Synchrony Medical Inc. filed with the SEC on 12 September 2025, one of 5 people that filing names.
Kevin Kotler is named as Director on the Form D that Synchrony Medical Inc. filed with the SEC on 12 September 2025, one of 5 people that filing names.
Elad Dushack is named as Director on the Form D that Synchrony Medical Inc. filed with the SEC on 12 September 2025, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2025-09-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Synchrony Medical Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Synchrony Medical Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Synchrony Medical Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Synchrony Medical Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Synchrony Medical Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Synchrony Medical Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Northern New Jersey
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/synchrony-medical-inc-form-d-25000001